After Alemtuzumab Induction, Tac plus MMF Is Superior to CsA plus MMF in Pediatric Kidney Transplantation.

被引：0
|
作者：
Kaabak, M. [1 ]
Babenko, N. [1 ]
Zokoyev, A. [1 ]
Shapiro, R. [2 ]
机构：
[1] Boris Petrovsky SCS, Moscow, Russia
[2] Mt Sinai Hosp, New York, NY 10029 USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2016年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
C40
引用
收藏
页码：614 / 614
页数：1
相关论文
共 50 条
  • [31] Sirolimus (RAP) plus cyclosporine microemulsion (CSA) is associated with a greater risk for renal function deterioration vs. mycophenolate mofetil (MMF) plus CSA.
    Meier-Kriesche, HU
    Loveland, JJ
    Steffen, BJ
    Chu, AH
    Gotz, V
    Gordon, RD
    Morris, JA
    Kaplan, B
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 218 - 219
  • [32] REDUCED COMPLICATIONS AFTER EARLY STEROID WITHDRAWAL IN PAEDIATRIC KIDNEY RECIPIENTS: DACLIZUMAB (DAC), TACROLIMUS (TAC) AND MYCOPHENOLATE MOFETIL (MMF) VERSUS TAC, MMF AND STEROIDS (TWIST STUDY)
    Watson, A. R.
    Grenda, R.
    Trompeter, R. S.
    PEDIATRIC NEPHROLOGY, 2009, 24 (09) : 1799 - 1799
  • [33] Therapeutic levels of mycophenolic acid under fixed doses of MMF on the first two months after kidney transplantation.
    Pereira, LM
    de Castro, MCR
    Mattos, RM
    Ventura, CG
    Sumita, NM
    Mendes, ME
    Romano, P
    Nahas, WC
    Ianhez, LE
    David-Neto, E
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 255 - 255
  • [34] MMF-based regimen in maintenance therapy after kidney transplantation
    Wu, MJ
    Shu, KH
    Cheng, CH
    Chen, CH
    Lian, JD
    TRANSPLANTATION PROCEEDINGS, 2000, 32 (07) : 1748 - 1750
  • [35] Efficacy and Safety of Desensitization Protocol Based On Rituximab Plus MMF in ABO-Incompatible Kidney Transplantation Without Splenectomy
    Takahashi, K.
    Saito, K.
    Takahara, S.
    Fuchinoue, S.
    Yagisawa, T.
    Aikawa, A.
    Watarai, Y.
    Yoshimura, N.
    Tanabe, K.
    Morozumi, K.
    Shimazu, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
  • [36] 5 Year of Minimalist Immunosuppression - Alemtuzumab Induction and Tacrolimus Monotherapy without Steroids or MMF in Renal Transplantation
    Chan, K.
    Galliford, J.
    Goodall, D.
    Cairns, T. D. H.
    Charif, R.
    Hakim, N.
    Palmer, A.
    Papalois, P.
    McLean, A.
    Taube, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 317 - 317
  • [37] Allograft Failure After Alemtuzumab Induction in Renal Transplantation.
    Willicombe, M.
    Goodall, D.
    Charif, R.
    Galliford, J.
    McLean, A.
    Taube, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 581 - 581
  • [38] Allograft Failure After Alemtuzumab Induction in Renal Transplantation.
    Willicombe, M.
    Goodall, D.
    Charif, R.
    Galliford, J.
    McLean, A.
    Taube, D.
    TRANSPLANTATION, 2014, 98 : 581 - 581
  • [39] Alemtuzumab Induction and Post-Transplant Glomerulonephritis in Kidney Transplantation.
    Koutroutsos, K.
    Willicombe, M.
    Charif, R.
    Roufosse, C.
    Loucaidou, M.
    Cook, T.
    Taube, D.
    TRANSPLANTATION, 2014, 98 : 534 - 535
  • [40] Surveillance Biopsy Findings with Alemtuzumab (ALZ) Induction in Kidney Transplantation.
    Madariaga, H.
    Ugarte, R.
    Drachenberg, C.
    Costa, N.
    Thomas, B.
    Bromberg, J.
    Weir, M.
    Haririan, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 454 - 454
12345